In silico bioisosteric replacements of hnRNP K ligands as anticancer lead compounds (2014)
Source: Current Physical Chemistry. Unidade: FCFRP
Subjects: MODELAGEM MOLECULAR, FÁRMACOS (PLANEJAMENTO), PROTEÍNAS
ABNT
SILVA, Vinícius Barreto da e LEOPOLDINO, Andréia Machado e SILVA, Carlos Henrique Tomich de Paula da. In silico bioisosteric replacements of hnRNP K ligands as anticancer lead compounds. Current Physical Chemistry, v. 4, n. 1, p. 30-34, 2014Tradução . . Disponível em: https://doi.org/10.2174/18779468113036660018. Acesso em: 13 jun. 2024.APA
Silva, V. B. da, Leopoldino, A. M., & Silva, C. H. T. de P. da. (2014). In silico bioisosteric replacements of hnRNP K ligands as anticancer lead compounds. Current Physical Chemistry, 4( 1), 30-34. doi:10.2174/18779468113036660018NLM
Silva VB da, Leopoldino AM, Silva CHT de P da. In silico bioisosteric replacements of hnRNP K ligands as anticancer lead compounds [Internet]. Current Physical Chemistry. 2014 ; 4( 1): 30-34.[citado 2024 jun. 13 ] Available from: https://doi.org/10.2174/18779468113036660018Vancouver
Silva VB da, Leopoldino AM, Silva CHT de P da. In silico bioisosteric replacements of hnRNP K ligands as anticancer lead compounds [Internet]. Current Physical Chemistry. 2014 ; 4( 1): 30-34.[citado 2024 jun. 13 ] Available from: https://doi.org/10.2174/18779468113036660018